Merck and Moderna’s Intismeran Autogene Plus Keytruda Meets Phase 3 RFS and DMFS Endpoints in Resected Melanoma
FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma
FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
Human Connection in Cancer Care with Dr. Aleksandra Filipovic - CancerWorld
ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC
oncoHUB and OncoDaily Announce Strategic Partnership to Strengthen Ukrainian Oncology
Bridging the Care Gap: Expanding Humanitarian Access to CLL Treatment Across LMICs
Simplify Your ESO College Enrolment With Our New 3-Year Plan - ESO
The Level 2 Advanced Course on Breast Cancer Surgery, organized by the European Society of Surgical Oncology (ESSO), will take place on 22–24 October 2026 at Hotel NH Danube City […]
